Improved control of sars-cov-2 by treatment with nucleocapsid-specific monoclonal antibody

HIGHLIGHTS

• who: Tanushree Dangi and colleagues from the DepartmentNorthwestern University, Cardiff, United Kingdom have published the research work: Improved control of SARS-CoV-2 by treatment with nucleocapsid-specific monoclonal antibody, in the Journal: (JOURNAL)
• what: The authors show that mice that received nucleocapsid-specific sera or a nucleocapsid-specific mAb exhibited enhanced control of SARS-CoV-2.
• how: To understand the role of nucleocapsid-specific humoral responses during SARS-CoV-2 infection the authors developed a prime-boost vaccine regimen that elicited high levels of nucleocapsid-specific antibodies which were later used in . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.